染色素作为一个旧的和新的抗癌点
Jacques Neefjes1, Katerina Gurova2, Jay Sarthy3
1Department of Cell and Chemical Biology and Oncode Institute, LUMC, Einthovenweg 20, 2333, ZC, Leiden, The Netherlands.
Trends in cancer
|June 2, 2024
概括
染色质修饰剂在癌症中经常发生突变,但破坏DNA的化疗是标准的. 这篇综述介绍了像 antracyclines 这样的小分子对染色体的"损伤",并提出了新的癌症治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 染色质修饰剂在各种癌症中经常发生突变.
- 目前的癌症治疗通常针对DNA损伤,尽管染色体调节者的突变.
- 在治疗染色体相关遗传变异的癌症方面存在差距.
研究的目的:
- 引入"染色体损伤"概念作为治疗目标.
- 为了突出忽视的染色素向化疗剂.
- 探索用于癌症治疗的新型染色体破坏剂.
主要方法:
- 审查有关染色体修饰剂和癌症的现有文献.
- 对诱导蛋白质-DNA相互作用的非遗传损伤的小分子的分析.
- 专注于人环素作为染色素向剂的案例研究.
主要成果:
- 建立了"染色体损伤"的概念,与DNA损伤区分开来.
- 鉴定出人环素作为临床相关的染色体损伤剂.
- 突出了被忽视的染色素向疗法的潜力.
结论:
- "染色体损伤"代表了癌症治疗的新范式.
- 人环素和类似的药物为染色体乱的癌症提供治疗途径.
- 对染色体损伤剂的进一步研究可以改善癌症治疗结果.
相关概念视频
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Spreading of Chromatin Modifications
8.3K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.3K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Histone Variants at the Centromere
4.3K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.3K
Inheritance of Chromatin Structures
6.2K
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
6.2K


